- Home
- DYNX vs BDMD Comparison
DYNX vs BDMD Comparison
Compare DYNX & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYNX
- BDMD
- Stock Information
- Founded
- DYNX 2024
- BDMD 2012
- Country
- DYNX United States
- BDMD China
- Employees
- DYNX N/A
- BDMD N/A
- Industry
- DYNX
- BDMD
- Sector
- DYNX
- BDMD
- Exchange
- DYNX NYSE
- BDMD NYSE
- Market Cap
- DYNX 221.3M
- BDMD 196.9M
- IPO Year
- DYNX 2024
- BDMD N/A
- Fundamental
- Price
- DYNX $10.06
- BDMD $4.41
- Analyst Decision
- DYNX
- BDMD
- Analyst Count
- DYNX 0
- BDMD 0
- Target Price
- DYNX N/A
- BDMD N/A
- AVG Volume (30 Days)
- DYNX 13.6K
- BDMD 30.5K
- Earning Date
- DYNX 01-01-0001
- BDMD 01-01-0001
- Dividend Yield
- DYNX N/A
- BDMD N/A
- EPS Growth
- DYNX N/A
- BDMD 18.86
- EPS
- DYNX N/A
- BDMD 0.49
- Revenue
- DYNX N/A
- BDMD $37,037,108.00
- Revenue This Year
- DYNX N/A
- BDMD N/A
- Revenue Next Year
- DYNX N/A
- BDMD N/A
- P/E Ratio
- DYNX N/A
- BDMD $7.90
- Revenue Growth
- DYNX N/A
- BDMD 17.73
- 52 Week Low
- DYNX $9.78
- BDMD $1.05
- 52 Week High
- DYNX $10.48
- BDMD $12.50
- Technical
- Relative Strength Index (RSI)
- DYNX N/A
- BDMD N/A
- Support Level
- DYNX N/A
- BDMD N/A
- Resistance Level
- DYNX N/A
- BDMD N/A
- Average True Range (ATR)
- DYNX 0.00
- BDMD 0.00
- MACD
- DYNX 0.00
- BDMD 0.00
- Stochastic Oscillator
- DYNX 0.00
- BDMD 0.00
About DYNX DYNAMIX CORP
Dynamix Corp is a blank check company.
About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.